Meredith Packer

Director Nava Therapeutics

Meredith Packer is Director of Analytical Development at Nava Therapeutics, with deep expertise in analytical and process development for gene editing and nucleic acid–based therapeutics. She has over a decade of experience spanning Moderna, Tome Biosciences, and Mirai Bio, specializing in assay development, CMC analytics, and supporting advancement of next-generation genetic medicines.

Seminars

Thursday 19th November 2026
Strengthen Targeted LNP Performance Through Advanced Characterization Strategies
11:30 am
  • Develop quantitative and qualitative assays to accurately characterize targeted LNP composition and surface modifications
  • Assess protein quality, conjugation efficiency, and surface integrity to ensure consistent targeting performance
  • Link analytical characterization to biological function to support robust development, comparability, and translational success
Meredith Packer
View all Speakers
View Event Brochure